The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.
European journal of endocrinology / European Federation of Endocrine Societies 2014 Jan 170 (1): 55-61.
Vannucchi Guia, Covelli Danila, Campi Irene, Origo Daniele, Currò Nicola, Cirello Valentina, Dazzi Davide, Beck-Peccoz Paolo, Salvi Mar
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: